Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 8.1 Form of Tax Opinion of Wilson Sonsini Goodrich & Rosati, P.C.
- 8.2 Form of Tax Opinion of Gibson, Dunn & Crutcher LLP
- 23.1 Consent of KPMG LLP, Independent Registered Public Accounting Firm of Arca Biopharma, Inc
- 23.2 Consent of Pricewaterhousecoopers LLP, Independent Registered Public Accounting Firm of Oruka Therapeutics, Inc
- Download Excel data file
- View Excel data file
Associated filings
- 1 Aug 24 424B3 Prospectus supplement
- 25 Jul 24 EFFECT Notice of effectiveness
- 22 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
9 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 18 Jun 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 May 24 S-4 Registration of securities issued in business combination transactions
ORKA similar filings
- 9 Jul 24 Registration of securities issued in business combination transactions (amended)
- 13 May 24 Registration of securities issued in business combination transactions
- 30 Oct 08 Registration of securities issued in business combination transactions
- 27 Nov 02 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of ARCA biopharma, Inc. of our report dated May 13, 2024 relating to the financial statement of Oruka Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
July 9, 2024